Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.
2.

Clinically relevant changes in family history of cancer over time.

Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE.

JAMA. 2011 Jul 13;306(2):172-8. doi: 10.1001/jama.2011.955.

3.

Breast, colorectal, and skin cancer screening practices and family history of cancer in U.S. women.

Shah M, Zhu K, Palmer RC, Jatoi I, Shriver C, Wu H.

J Womens Health (Larchmt). 2007 May;16(4):526-34.

PMID:
17521256
4.

Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening.

Vertosick EA, Poon BY, Vickers AJ.

J Urol. 2014 Sep;192(3):724-8. doi: 10.1016/j.juro.2014.03.032. Epub 2014 Mar 15.

6.

Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men.

Shah M, Zhu K, Palmer RC, Wu H.

Prev Med. 2007 May;44(5):459-64. Epub 2007 Jan 9.

PMID:
17320159
7.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

8.

Cancer screening rates in individuals with different life expectancies.

Royce TJ, Hendrix LH, Stokes WA, Allen IM, Chen RC.

JAMA Intern Med. 2014 Oct;174(10):1558-65. doi: 10.1001/jamainternmed.2014.3895.

PMID:
25133746
9.

Family history of hormonal cancers and colorectal cancer risk: a case-control study conducted in Ontario.

Jang JH, Cotterchio M, Gallinger S, Knight JA, Daftary D.

Int J Cancer. 2009 Aug 15;125(4):918-25. doi: 10.1002/ijc.24385.

10.

Population-based screening for hereditary breast cancer in a region of North-Central Italy.

Casadei S, Falcini F, Naldoni C, Amadori D, Calistri D.

Int J Mol Med. 2002 Sep;10(3):299-305.

PMID:
12165804
11.

Association between documented family history of cancer and screening for breast and colorectal cancer.

Carney PA, O'Malley JP, Gough A, Buckley DI, Wallace J, Fagnan LJ, Morris C, Mori M, Heintzman JD, Lieberman D.

Prev Med. 2013 Nov;57(5):679-84. doi: 10.1016/j.ypmed.2013.08.031. Epub 2013 Sep 9.

12.

Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.

Sellers TA, Potter JD, Rich SS, Drinkard CR, Bostick RM, Kushi LH, Zheng W, Folsom AR.

J Natl Cancer Inst. 1994 Dec 21;86(24):1860-5.

PMID:
7990161
13.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

14.

Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour.

Zarychanski R, Chen Y, Bernstein CN, H├ębert PC.

CMAJ. 2007 Sep 11;177(6):593-7.

15.
16.

Breast and colorectal cancer screening and sources of cancer information among older women in the United States: results from the 2003 Health Information National Trends Survey.

Coughlin SS, Berkowitz Z, Hawkins NA, Tangka F.

Prev Chronic Dis. 2007 Jul;4(3):A57. Epub 2007 Jun 15. Erratum in: Prev Chronic Dis. 2007 Oct;4(4):A114.

17.

Confirmation of family cancer history reported in a population-based survey.

Mai PL, Garceau AO, Graubard BI, Dunn M, McNeel TS, Gonsalves L, Gail MH, Greene MH, Willis GB, Wideroff L.

J Natl Cancer Inst. 2011 May 18;103(10):788-97. doi: 10.1093/jnci/djr114. Epub 2011 May 11.

18.

Cancer genetics clinics and the surgeon: a valuable role for family history screening.

Williams GL, Gray J, Beynon J.

Ann R Coll Surg Engl. 2007 Mar;89(2):127-9.

19.
20.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

Supplemental Content

Support Center